318 related articles for article (PubMed ID: 12617722)
1. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
Kotera J; Grimes KA; Corbin JD; Francis SH
Biochem J; 2003 Jun; 372(Pt 2):419-26. PubMed ID: 12617722
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
Corbin JD; Turko IV; Beasley A; Francis SH
Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
[TBL] [Abstract][Full Text] [Related]
3. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
Gopal VK; Francis SH; Corbin JD
Eur J Biochem; 2001 Jun; 268(11):3304-12. PubMed ID: 11389733
[TBL] [Abstract][Full Text] [Related]
4. Allosteric sites of phosphodiesterase-5 sequester cyclic GMP.
Kotera J; Francis SH; Grimes KA; Rouse A; Blount MA; Corbin JD
Front Biosci; 2004 Jan; 9():378-86. PubMed ID: 14766375
[TBL] [Abstract][Full Text] [Related]
5. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
6. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV; Ballard SA; Francis SH; Corbin JD
Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
[TBL] [Abstract][Full Text] [Related]
8. A conserved serine juxtaposed to the pseudosubstrate site of type I cGMP-dependent protein kinase contributes strongly to autoinhibition and lower cGMP affinity.
Busch JL; Bessay EP; Francis SH; Corbin JD
J Biol Chem; 2002 Sep; 277(37):34048-54. PubMed ID: 12080049
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of cGMP-dependent protein kinase Ibeta is mediated by an extensive amino-terminal leucine zipper motif, and dimerization modulates enzyme function.
Richie-Jannetta R; Francis SH; Corbin JD
J Biol Chem; 2003 Dec; 278(50):50070-9. PubMed ID: 12933804
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase.
Wall ME; Francis SH; Corbin JD; Grimes K; Richie-Jannetta R; Kotera J; Macdonald BA; Gibson RR; Trewhella J
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2380-5. PubMed ID: 12591946
[TBL] [Abstract][Full Text] [Related]
12. Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP.
Okada D; Asakawa S
Biochemistry; 2002 Jul; 41(30):9672-9. PubMed ID: 12135389
[TBL] [Abstract][Full Text] [Related]
13. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP specifically suppresses Type-Ialpha cGMP-dependent protein kinase expression by ubiquitination.
Dey NB; Busch JL; Francis SH; Corbin JD; Lincoln TM
Cell Signal; 2009 Jun; 21(6):859-66. PubMed ID: 19168131
[TBL] [Abstract][Full Text] [Related]
15. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
16. Activation by cyclic GMP binding causes an apparent conformational change in cGMP-dependent protein kinase.
Chu DM; Corbin JD; Grimes KA; Francis SH
J Biol Chem; 1997 Dec; 272(50):31922-8. PubMed ID: 9395541
[TBL] [Abstract][Full Text] [Related]
17. Isolated regulatory domains of cGMP-dependent protein kinase Ialpha and Ibeta retain dimerization and native cGMP-binding properties and undergo isoform-specific conformational changes.
Richie-Jannetta R; Busch JL; Higgins KA; Corbin JD; Francis SH
J Biol Chem; 2006 Mar; 281(11):6977-84. PubMed ID: 16407222
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
[TBL] [Abstract][Full Text] [Related]
19. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase.
Liu L; Underwood T; Li H; Pamukcu R; Thompson WJ
Cell Signal; 2002 Jan; 14(1):45-51. PubMed ID: 11747988
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation increases affinity of the phosphodiesterase-5 catalytic site for tadalafil.
Bessay EP; Blount MA; Zoraghi R; Beasley A; Grimes KA; Francis SH; Corbin JD
J Pharmacol Exp Ther; 2008 Apr; 325(1):62-8. PubMed ID: 18199808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
